Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Applied Rigaku Technologies, Inc. (ART) is a subsidiary of Rigaku Corporation that specializes in the design and manufacture of benchtop and process Energy Dispersive X-ray Fluorescence (EDXRF) spectrometers. The company provides advanced analytical solutions for non-destructive elemental analysis across various industries, including pharmaceuticals, environmental monitoring, and petroleum. Their products, such as the NEX series, are used in life sciences for screening catalyst residues, heavy metals, and elemental impurities in drug substances and products. ART is headquartered in Austin, Texas, and serves a global market with specialized X-ray instrumentation designed for both laboratory and industrial environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Applied Rigaku Technologies.